Dasatinib monohydrate

• Description:

  Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  506.03

• Molecular Formula:

  C22H28ClN7O3S

• Notes:

  Research use only, not for human use.

• Receptor:

  Abl| c-Kit (D816V) | c-Kit (wt) | EphA2| Src

• CAS Number:

  863127-77-9